What patients praise: Fast prescription approvals multiple reviewers report same-day or 48-hour turnaround Effective weight loss results on injectable formats, with losses of 12 lbs in 6 weeks and similar results cited Responsive provider messaging for clinical questions Successful insurance coordination multiple reviewers describe Zealthy successfully navigating prior authorizations and getting brand-name GLP-1s covered at roughly $25/month Affordable compounded pricing relative to brand-name retail costs Common complaints: Recurring charges after cancellation described by a substantial volume of reviewers as ongoing for months or years, with multiple reviewers filing credit card disputes and BBB complaints Billing under alternate merchant names (ZFit, GLP1, FitRX) after cancellation, making disputes more difficult to identify and file Charges taken before prescription approval some reviewers report paying before clinical review and not receiving medication or refunds Long shipping times and medication not arriving some reviewers report waiting more than three weeks from sign-up to first order Customer service described as difficult to reach, with email as the primary channel and phone support inconsistently available Compounding Pharmacies Used Zealthy-sourced compounded drugs are prepared by a state-licensed sterile compounding pharmacy, but the specific pharmacy or pharmacies are not publicly named on the website
Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisks Ozempic and Wegovy and Eli Lillys Mounjaro and Zepbound
In 1993, Sikiric and colleagues in Zagreb isolated a cytoprotective protein from human gastric juice, called Body Protection Compound (BPC), whose fragment 157 (15 amino acids) reproduces most of its regenerative activity
Peters et al., 2013
454 Strategic modulation of the gut mycobiota through dietary interventions, fecal microbiota transplantation, probiotic supplementation, and prebiotic administration has therapeutic potential in enhancing immunotherapy efficacy while mitigating immune-related adverse events
Researchers have observed the drugs impact on diseases other than diabetes and obesity in clinical trials and among people taking the medications in real-world settings
